Companies: 10,795·Total market cap: $144.5T
Metagenomi, Inc. Common Stock

Metagenomi, Inc. Common Stock

MGXNASDAQHealthcare● Active
$1.29
+$0.01(+0.78%)
Market Cap$48564449
P/E Ratio
52W High$3.95
52W Low$1.24
Overview

Metagenomi, Inc. Common Stock (MGX) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · MGX · as of Jun 9, 2026

Key Statistics

EPS (TTM)mgx eps ttm · mgx earnings per shareEarnings history
PE Ratio (TTM)mgx pe ratio ttm · mgx price to earningsPE Ratio deep dive
Revenue (TTM)mgx revenue ttm · mgx annual revenueFull revenue history
Dividend YieldNo Dividenddoes mgx pay dividends · mgx dividend yieldDividend history
Shares Outstandingmgx shares outstanding · mgx floatShares outstanding history
Next EarningsTBAmgx earnings date · mgx next earningsEarnings history

About Metagenomi, Inc. Common Stock

CEOJian Irish
IPO DateApr 6, 2006
Employees202
CountryUS

Metagenomi, Inc. Common Stock Metagenomi, Inc. operates as a biotechnology company focused on gene editing, committed to developing therapeutic solutions for patients. The company utilizes a distinctive genome editing toolkit, sou…

what is metagenomi, inc. common stock · mgx stock overview · metagenomi, inc. common stock company profile · who is metagenomi, inc. common stock ceo · mgx NASDAQ · metagenomi, inc. common stock headquarters · metagenomi, inc. common stock business segments

About Stock Overview & Key Data

Metagenomi, Inc. Common Stock (MGX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Apr 6, 2006. As of the latest trading session, MGX stock price is $1.29, with a market capitalization of $48.6M. The stock has returned — over the past 12 months and — year-to-date.

Frequently Asked Questions

As of the latest trading session, Metagenomi, Inc. Common Stock (MGX) stock price is $1.29. The stock is traded on NASDAQ under the ticker symbol MGX. The 52-week range is $1.24 – $3.95.

MGX stock priceMGX quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice